Friday, March 8, 2013

• Elan Provides Update on Tysabri Transaction and $1bn Share RepurchaseBusiness Wire (Fri, Mar 8)

Thursday, March 7, 2013

• Elan to Share Tysabri ProceedsZacks (Thu, Mar 7)
• These Drug Partners are Headed in Opposite Directionsat Motley Fool (Thu, Mar 7)

Wednesday, March 6, 2013

• Royalty Pharma says ready to move quickly on Elan offerat Reuters (Wed, Mar 6)
• BRIEF-Elan says proposal by Royalty Pharma remains an indication of interestat Reuters (Wed, Mar 6)
• Elan's response to Royalty Pharma statementat theflyonthewall.com (Wed, Mar 6)
• Elan’s Response to Royalty Pharma Statement of TodayBusiness Wire (Wed, Mar 6)
• Royalty Pharma says committed to aquiring Elan on previous termstheflyonthewall.com (Wed, Mar 6)
• Royalty Pharma Statement Regarding Elan ProposalPR Newswire (Wed, Mar 6)

Tuesday, March 5, 2013

• Several Catalysts Behind My Decision To Establish A Position In Biogen Idecat Seeking Alpha (Tue, Mar 5)

Monday, March 4, 2013

• Elan to Start Paying Dividendsat Motley Fool (Mon, Mar 4)
• Elan Unlocks New Dividend Policy to Stave Off Hostile Bidat Fox Business (Mon, Mar 4)
• Early Movers: RIG, LVS, YHOO & Moreat CNBC (Mon, Mar 4)
• Elan Announces Further Unlocking of Value To Benefit ShareholdersBusiness Wire (Mon, Mar 4)

Saturday, March 2, 2013

• [$$] Italian Vote Ramps Up Euro Zone's Angstat Barrons.com (Sat, Mar 2)

Thursday, February 28, 2013

• 101 Reasons to Stay Away From Drugs for This Diseaseat Motley Fool (Thu, Feb 28)
• VIX - Options Volatility And Market Sonar: Wednesday Recapat Seeking Alpha (Thu, Feb 28)
• You Have to Love a Lucrative 'Drug Deal'TheStreet (Thu, Feb 28)
• You Have to Love a Lucrative 'Drug Deal'at TheStreet (Thu, Feb 28)
• Elan Announces the Appointment of Mr. John Given as General CounselBusiness Wire (Thu, Feb 28)

Wednesday, February 27, 2013

• What Makes Biogen Idec One of America's Best Companiesat Motley Fool (Wed, Feb 27)
• Royalty Pharma to approach Elan shareholders, reuters reportstheflyonthewall.com (Wed, Feb 27)
• Cost Cutting Is Nice, But Don't Forget About Salesat Motley Fool (Wed, Feb 27)

Tuesday, February 26, 2013

• Royalty Pharma Eyes Elan Corp.Zacks (Tue, Feb 26)
• Winner, Loser, and a Lesson From This Biotech's Demiseat Motley Fool (Tue, Feb 26)

Add ELN News to My Yahoo!